Upload
arabella-jefferson
View
220
Download
4
Tags:
Embed Size (px)
Citation preview
Funding Update: 2013 – 2015September 10, 2013
1
2China 2013
3
OVERVIEW
•MR Initiative Annual Expenditure 2001-2013
•MR Initiative Annual Donations 2001-2013; Financial
Resource Requirements through 2015
•MR Initiative Financial Resource Requirements - detail
•MR Initiative donors, 2001 - 2013
•measles & rubella moving ahead
•Challenges to implementation for MR Initiative
0
20
40
60
80
100
120
140
160
180
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
$ U
S M
illi
on
Donations Series2
* Excluding country contributions
MR Initiative Annual Expenditure, 2001-2013
Total expenditure 2001-2013 = $1,008 million
4
1159
36 38 44
94
Measles & Rubella Initiative Annual Donations 2001-2015 and Financial Resource Requirements,
Projections, Funding Gap 2013-2015*
0
50
100
150
200
250
300
350
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
$ U
S M
illio
n
Donations Funds Projected or Pledged Funding gap (includes PSC)
* Excludes all country contributions and direct social mobilization funding from partners
5
0
50
100
150
200
250
300
350
400
2013 2014 2015
$ U
S M
illio
nMeasles & Rubella Initiative Financial Resource
Requirements, Projections, Funding Gap 2013-2015
Anticipated Country ContributionsDonor Funds Projected/Pledged/Received
32
31
18
47
Anticipated GAVI Contribution (Rubella)Funding Gap (includes PSC)
Total Funding Gap 2014-2015: US $65 million
6
Resource Requirements by Major Category of Activity, 2014-2015
0
50
100
150
200
250
300
350
400
2014 2015
$U
S M
illio
n
Measles SIAs Measles Rubella SIAs Technical Assistance Outbreak Response
Surveillance / Lab Coverage Surveys Research Communication
Total Cost 2014-2015: US $557 million
7
MR Initiative Donors, 2001-2013
* Includes ARC/UNF and other partners
CDCJICA
NorwayDFID
Civil SocietyARC*LDS
Lions
UNUNICEF
UNF*
FoundationsGates
Private SectorBD
MerckVodaphone
OtherGAVI/IFFIm
8
Where is the Measles & Rubella Initiative Headed?Toward regional achievement of Measles Rubella Elimination Goals by or before 2020
Improvement of routine coverage and timely and high quality SIAsExpanded use of accurate data for decision making
• 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination) - missed
• 2013 potential SEARO elimination goal set (waiting), begin MR introduction campaigns with GAVI support (done)
• 2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination); continue to set regional rubella elimination goals as appropriate
• 2020 Measles goal in AFRO (elimination)
Critical Elements for Success
• Political leadership
• Timely funding (donor and national governments)
• Adequate time for planning and social mobilization (9 months)
• Well performing surveillance, analysis & use of data to improve coverage9
Challenges to Implementation for MR Initiative
• Lack of timely and sufficient funding: few multiyear grants• Ensuring high quality SIA’s (increased training and social mobilization
cost, increased technical assistance request)• Providing strategic support for non-GAVI eligible countries (TA, Surveillance)
• Increased surveillance cost (including lab, coverage surveys)• Projecting target age range for SIA’s several years in advance• Projecting cost to MR Initiative for target populations above 59 months
for GAVI funded measles SIA’s in 6 large countries • Routine immunization: scale up of MCV1, increased MCV2 introduction
and coverage, other routine strengthening immunization activities
10